Effects of Acupuncture at Sanyinjiao (SP6) on Prostaglandin Levels in Primary Dysmenorrhea Patients
暂无分享,去创建一个
[1] C. Farquhar,et al. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding (Review) , 2018 .
[2] H. M. Tse,et al. Effects of SP6 acupressure on pain and menstrual distress in young women with dysmenorrhea. , 2010, Complementary therapies in clinical practice.
[3] Jian-ping Liu,et al. Systematic review of clinical trials of acupuncture‐related therapies for primary dysmenorrhea , 2008, Acta obstetricia et gynecologica Scandinavica.
[4] N. Shenker,et al. Demystifying acupuncture. , 2008, Rheumatology.
[5] D. Kang,et al. Effects of acupressure on dysmenorrhea and skin temperature changes in college students: a non-randomized controlled trial. , 2007, International journal of nursing studies.
[6] Jennifer Kerns,et al. Oral contraceptives: side effects and depression in adolescent girls. , 2007, Contraception.
[7] F. Khan-dawood,et al. Differential suppression of menstrual fluid prostaglandin F2a, prostaglandin E2, 6-keto prostaglandin F1a and thromboxane B2 by suprofen in women with primary dysmenorrhea. , 2007, Prostaglandins & other lipid mediators.
[8] Guang-ying Huang,et al. [Effect of acupuncture at Sanyinjiao (SP 6) on glucose metabolism in the patient of dysmenorrhea]. , 2006, Zhongguo zhen jiu = Chinese acupuncture & moxibustion.
[9] M. Burnett,et al. Primary dysmenorrhea consensus guideline. , 2005, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[10] M. Burnett,et al. Prevalence of primary dysmenorrhea in Canada. , 2005, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[11] Xiguang Chen,et al. Effects of scorpion venom bioactive polypolypeptides on platelet aggregation and thrombosis and plasma 6-keto-PG F1alpha and TXB2 in rabbits and rats. , 2005, Toxicon : official journal of the International Society on Toxinology.
[12] Chung-Hey Chen,et al. Effects of acupressure at the Sanyinjiao point on primary dysmenorrhoea. , 2004, Journal of advanced nursing.
[13] A. Hartz,et al. The natural history of primary dysmenorrhoea: a longitudinal study , 2004, BJOG : an international journal of obstetrics and gynaecology.
[14] J. Rock,et al. COX-2 Inhibitors and Their Role in Gynecology , 2002, Obstetrical & gynecological survey.
[15] S. Kelder,et al. Prevalence and impact of dysmenorrhea on Hispanic female adolescents. , 2000, Archives of pediatrics & adolescent medicine.
[16] L. Valentin,et al. Effects of a Vasopressin Antagonist in Women with Dysmenorrhea , 2000, Gynecologic and Obstetric Investigation.
[17] M. Tramèr,et al. Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use , 2000, Pain.
[18] R. Dmitrović. A transvaginal color doppler study of uterine blood flow in primary dysmenorrhea , 2000, Acta obstetricia et gynecologica Scandinavica.
[19] F. Benedetti,et al. Neuropharmacological Dissection of Placebo Analgesia: Expectation-Activated Opioid Systems versus Conditioning-Activated Specific Subsystems , 1999, The Journal of Neuroscience.
[20] J. Sandkühler,et al. The organization and function of endogenous antinociceptive systems , 1996, Progress in Neurobiology.
[21] C. Zhan. Treatment of 32 cases of dysmenorrhea by puncturing hegu and sanyinjiao acupoints. , 1990, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.
[22] E. Woods,et al. Adolescents' compliance with the use of oral contraceptives. , 1987, JAMA.
[23] T. Saldeen,et al. 6-keto-prostaglandin F1α/thromboxane B2 ratio in vascular and lung tissue , 1983 .
[24] T. Saldeen,et al. 6-keto-prostaglandin F1 alpha/thromboxane B2 ratio in vascular and lung tissue. , 1983, Thrombosis research.
[25] V. Lundström. The Myometrial Response to Intra‐Uterine Administration of PGF2α and PGE2 in Dysmenorrheic Women , 1977, Acta obstetricia et gynecologica Scandinavica.
[26] B. Pomeranz,et al. Naloxone blockade of acupuncture analgesia: endorphin implicated. , 1976, Life sciences.